Search Results

Filter
  • 1-10 of  1,404 results for ""Absorbable Implants""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Assessment of Cutting-Balloon Angioplasty with Novel Bioabsorbable Polymer-Coated Everolimus-Eluting Stent in Treating Calcified Coronary Lesions Guided by Intravascular Ultrasound (CUPID Trial): study design and protocol.

  • Authors : Ahn J; Department of Internal Medicine, Daejeon Eulji Medical Center, Eulji University School of Medicine, Daejeon, Korea.; Yu H

Subjects: Everolimus*/Everolimus*/Everolimus*/administration & dosage ; Drug-Eluting Stents* ; Ultrasonography, Interventional*

  • Source: Trials [Trials] 2024 Oct 29; Vol. 25 (1), pp. 727. Date of Electronic Publication: 2024 Oct 29.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

Record details

×
Editorial & Opinion

Editorial: Short-term DAPT after bioabsorable polymer synergy stents.

  • Authors : Finn AV; CVPath Institute, Gaithersburg, MD, USA; University of Maryland, School of Medicine, Baltimore, MD, USA. Electronic address: .

Subjects: Absorbable Implants* ; Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/instrumentation ; Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/adverse effects

  • Source: Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2024 Oct; Vol. 67, pp. 84-86. Date of Electronic Publication: 2024 Jun 08.Publisher: Elsevier Country of Publication: United States NLM ID: 101238551 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Application of the Academic Research Consortium High Bleeding Risk criteria in patients treated with coronary bioresorbable polymer everolimus-eluting stents: Insights from the POEM trial.

  • Authors : Popolo Rubbio A; IRCCS Policlinico San Donato, Department of Clinical and Interventional Cardiology, San Donato Milanese, Milan, Italy.; Testa L

Subjects: Drug-Eluting Stents* ; Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/adverse effects ; Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/instrumentation

  • Source: Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2024 Oct; Vol. 67, pp. 77-83. Date of Electronic Publication: 2024 Apr 16.Publisher: Elsevier Country of Publication: United States NLM ID: 101238551 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human study.

  • Authors : Seguchi M; Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technical University Munich, Munich, Germany.; Aytekin A

Subjects: Tomography, Optical Coherence*/Tomography, Optical Coherence*/Tomography, Optical Coherence*/methods ; Magnesium* ; Ultrasonography, Interventional*/Ultrasonography, Interventional*/Ultrasonography, Interventional*/methods

  • Source: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology [EuroIntervention] 2024 Sep 16; Vol. 20 Publisher: Société Europa édition Country of Publication: France NLM ID: 101251040 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Five-year outcomes of patients with diabetes mellitus treated with a sirolimus-eluting or a biolimus-eluting stents with biodegradable polymer. From the SORT OUT VII trial.

Subjects: Drug-Eluting Stents* ; Sirolimus*/Sirolimus*/Sirolimus*/administration & dosage ; Sirolimus*/Sirolimus*/Sirolimus*/analogs & derivatives

  • Source: Diabetes & vascular disease research [Diab Vasc Dis Res] 2024 Sep-Oct; Vol. 21 (5), pp. 14791641241283939.Publisher: Sage Publications Country of Publication: England NLM ID: 101234011 Publication Model: Print Cited Medium: Internet ISSN: 1752-8984

Record details

×
Academic Journal

Sirolimus-eluting iron bioresorbable scaffold versus cobalt-chromium everolimus-eluting stents in patients with coronary artery disease: Rationale and design of the IRONMAN-II trial.

  • Authors : Song L; Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; National Clinical Research Center for Cardiovascular Diseases, Beijing, China

Subjects: Everolimus*/Everolimus*/Everolimus*/administration & dosage ; Everolimus*/Everolimus*/Everolimus*/pharmacology ; Drug-Eluting Stents*

  • Source: American heart journal [Am Heart J] 2024 Sep; Vol. 275, pp. 53-61. Date of Electronic Publication: 2024 Jun 04.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744

Record details

×
Editorial & Opinion

Absorbable Drug Eluting Stents May Bring LIFE to the Treatment of Below the Knee Lesions in Peripheral Arterial Disease.

  • Authors : Nordanstig J; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Vascular Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.

Subjects: Peripheral Arterial Disease*/Peripheral Arterial Disease*/Peripheral Arterial Disease*/therapy ; Peripheral Arterial Disease*/Peripheral Arterial Disease*/Peripheral Arterial Disease*/surgery ; Peripheral Arterial Disease*/Peripheral Arterial Disease*/Peripheral Arterial Disease*/diagnostic imaging

  • Source: European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery [Eur J Vasc Endovasc Surg] 2024 Aug; Vol. 68 (2), pp. 146-148. Publisher: Elsevier Country of Publication: England NLM ID: 9512728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2165

Record details

×
Academic Journal

Clinical Value of Bioresorbable Scaffolds in Patients with Non-left Main Bifurcation Lesions Undergoing Percutaneous Coronary Intervention.

Subjects: Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/methods ; Absorbable Implants* ; Drug-Eluting Stents*

  • Source: Alternative therapies in health and medicine [Altern Ther Health Med] 2024 Aug; Vol. 30 (8), pp. 72-77.Publisher: InnoVision Communications Country of Publication: United States NLM ID: 9502013 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Clinical outcomes with biodegradable versus durable polymer drug-eluting stents in patients with ST-elevation myocardial infarction.

  • Authors : Araujo GN; Instituto de Cardiologia de Santa Catarina, São Jose, Brazil; Hospital Unimed Grande Florianopolis, São Jose, Brazil. Electronic address: .

Subjects: ST Elevation Myocardial Infarction*/ST Elevation Myocardial Infarction*/ST Elevation Myocardial Infarction*/therapy ; ST Elevation Myocardial Infarction*/ST Elevation Myocardial Infarction*/ST Elevation Myocardial Infarction*/mortality ; ST Elevation Myocardial Infarction*/ST Elevation Myocardial Infarction*/ST Elevation Myocardial Infarction*/diagnostic imaging

  • Source: Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2024 Aug; Vol. 65, pp. 52-57. Date of Electronic Publication: 2024 Mar 08.Publisher: Elsevier Country of Publication: United States NLM ID: 101238551 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Biodegradable Polymer Versus Polymer-Free Ultrathin Sirolimus-Eluting Stents: Analysis of the Stent Arm Registry From the HOST-IDEA Randomized Trial.

  • Authors : Han JK; Cardiovascular Center, Seoul National University Hospital, Republic of Korea (J.-K.H., S. Yang, D.H., S.-H. Park, J. Kang, H.-M. Yang, K.W. Park, H.-J. Kang, B.-K.K., H.-S. Kim).; Department of Internal Medicine, College of Medicine, Seoul National University, Republic of Korea (J.-K.H., H.-M. Yang, K.W. Park, H.-J. Kang, B.-K.K., H.-S. Kim).

Subjects: Drug-Eluting Stents* ; Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/instrumentation ; Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/Percutaneous Coronary Intervention*/adverse effects

  • Source: Circulation. Cardiovascular interventions [Circ Cardiovasc Interv] 2024 Jul; Vol. 17 (7), pp. e013585. Date of Electronic Publication: 2024 May 24.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101499602 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  1,404 results for ""Absorbable Implants""